Fig. 3From: Design of experiment-driven stability-indicating RP-HPLC method for the determination of tofacitinib in nanoparticles and skin matrixRepresentative HPLC chromatograms for a lowest quality control (LQC ~ 250 ng/mL), b highest quality control (HQC ~ 12,000 ng/mL, c acid hydrolysis, d base hydrolysis, e oxidation, f thermal conditionsBack to article page